(951) 694-3600
 

atx-101 Tag

A while back I wrote of a new treatment for sub mental fullness, better known as ‘double chin.’  Over the summer, I became increasing frustrated with Kythera, the company responsible for developing Kybella and bringing it through the arduous FDA approval process.  Kythera seemed to...

Kybella Just a quick update… ATX-101 has a new name, Kybella (deoxycholic acid).  The injectable treatment for sub mental fat or “double chin” is near on the horizon.  FDA approval has been secured.  Kybella has an anticipated release date of May 13th.  For more information, please see...

Double Chin Treatment ATX-101 Exciting news!  New treatment for double chin called ATX-101 is on the horizon. A Food and Drug Administration advisory committee recommended the approval of ATX-101, an experimental form of deoxycholic acid, for the treatment of submental (double chin) fat. First, a bit of biology,...